Financial statements Endopharm
Balance sheet of Endopharm
Company age:
Age:
5 y. 11 m. 18 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of ENDOPHARM
|
Year
|
2020
|
2021
|
2022
|
|---|---|---|---|
| Total assets | 3 299 990,62 | 3 188 436,78 | 3 097 256,59 |
| A. Fixed assets | 2 173 533,99 | 2 160 450,22 | 2 153 415,97 |
| B. Current assets | 1 126 456,63 | 1 027 986,56 | 943 840,62 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 3 299 990,62 | 3 188 436,78 | 3 097 256,59 |
| A. Equity | -1 691 936,51 | -1 796 869,16 | -1 932 357,57 |
| B. Liabilities and provisions for liabilities | 4 991 927,13 | 4 985 305,94 | 5 029 614,16 |
| I. Long-term liabilities | 2 526 421,31 | 2 841 489,09 | 2 968 209,10 |
| II. Short-term liabilities | 2 465 505,82 | 2 143 816,85 | 2 061 405,06 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.